Effectiveness of the Personalized Responses & Integrated Systems for Metabolism (PRISM) on Improving Insulin Resistance Among Adults With Metabolic Syndrome: A Pilot Study (PRISM-I)

Study acronym: PRISM-I
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 6 more changesShow less
    • Primary and study completion dates: Jul 2027 to Jun 2027
    • Start date changed from estimate of Jul 2026 to Sep 17, 2026
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 50 of 55 entries
    • Site details revised
    • Study description expanded, about 4 words
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The primary objective of the Personalized Responses \& Integrated Systems for Metabolism (PRISM-I) pilot study is to assess the feasibility of conducting a definitive randomized controlled trial evaluating precision lifestyle interventions for improving insulin resistance in adults with metabolic syndrome.
Trial Details
NCT Number NCT07710274
Lead Sponsor National University Health System, Singapore
Conditions
(from sponsor)		 Metabolic Syndrome (MetS)
Related terms Metabolic Syndrome
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov